# Post-Acute COVID-19 Syndrome trials: 128 new since Nov 2024

Updated November 4, 2026.

128 clinical studies in Post-Acute COVID-19 Syndrome were first posted on ClinicalTrials.gov from November 14, 2024 to November 4, 2026; 12 have an industry sponsor and 75 are recruiting or about to. The newest, NCT07916259, was posted on November 4, 2026: The Study of Brave-LC LDN Treatment Trial (National Institute of Allergy and Infectious Diseases (NIAID)).

## The full list

New Post-Acute COVID-19 Syndrome clinical trials: 128 rows for $6.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/post-acute-covid-19-syndrome

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 128
- Industry sponsored: 12
- Recruiting or not yet: 75
- Latest posted: November 4, 2026

## Newest trials

The newest 100 of 128, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07916259 | The Study of Brave-LC LDN Treatment Trial | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | Not yet recruiting | Post-acute COVID-19 Syndrome | 1,300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916259) |
| October 27, 2026 | NCT07899346 | Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome | Invivyd, Inc. | Phase 2 | Not yet recruiting | Long COVID, COVID-19 (SARS-CoV-2 Infection), COVID 19 Vaccine, COVID Long | 130 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899346) |
| October 22, 2026 | NCT07888673 | Transcraneal Magnetic Stimulation for Treatment of Non-nociceptive Pain in Chronic Diseases | Hospital Donostia | Not applicable | Completed | Stroke Sequelae, Chronic Pain, Fibromyalgia, Long COVID19 | 47 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888673) |
| October 19, 2026 | NCT07881029 | Cognitive Impairment and Return to Work in Long COVID | Hopitaux de Saint-Maurice | Observational | Completed | Long COVID | 55 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881029) |
| October 19, 2026 | NCT07880171 | Intensive Home-based Transcranial Direct Current Stimulation for Long COVID | Hospital de Basurto | Not applicable | Completed | Long COVID Fatigue, Brain Fog, Chronic Pain, Depression Anxiety Disorder | 40 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880171) |
| October 14, 2026 | NCT07874217 | Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study | Oxford Brookes University | Not applicable | Recruiting | ME/CFS, Fibromyalgia (FM), Long-COVID, Control Group | 40 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874217) |
| October 13, 2026 | NCT07871578 | Experiences and Care Pathways Shared on Social Media Regarding 5 Conditions Causing Chronic Pain | Central Hospital, Nancy, France | Observational | Completed | Lyme Borreliosis, Fibromyalgia, Rheumatoid Arthritis (RA), Post Acute COVID 19 Syndrome, Endometriosis | 501 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871578) |
| August 24, 2026 | NCT07783074 | Fatigue Investigation Using Digital Outcomes | Liliana Barrios | Observational | Recruiting | Multiple Sclerosis, Long Covid, Healthy | 122 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783074) |
| August 24, 2026 | NCT07781501 | Long-Term Study of COVID-19 Infection and Long COVID | University of North Carolina, Chapel Hill | Observational | Recruiting | SARS CoV-2 Post-Acute Sequelae | 500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781501) |
| August 18, 2026 | NCT07770022 | Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER) | University of California, San Francisco | Observational | Recruiting | Long Covid | 150 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770022) |
| August 14, 2026 | NCT07766512 | Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Long COVID, COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, Post-Acute COVID-19 | 900 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766512) |
| August 11, 2026 | NCT07757620 | Epigenetic Changes in Long COVID Patients | Istituti Clinici Scientifici Maugeri SpA | Observational | Active not recruiting | Long COVID-19 Syndrome, Long COVID Symptoms | 1,000 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07757620) |
| August 4, 2026 | NCT07745699 | Fully Remote, Telehealth-based Ketogenic Metabolic Therapy for Long COVID | National University of Natural Medicine | Not applicable | Completed | Long COVID Fatigue | 11 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745699) |
| August 4, 2026 | NCT07744451 | Kinesiotaping Versus Physiotherapy for Post-Covid-19 Back Pain | Medipol University | Not applicable | Completed | Post-COVID-19 Syndrome, Back Pain, Musculoskeletal Pain | 33 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07744451) |
| July 24, 2026 | NCT07726082 | Micro-choice-based Intervention for Multicausal Fatigue | University Hospital, Basel, Switzerland | Not applicable | Recruiting | Multicausal Fatigue, Fatigue, Post COVID Condition, Long COVID Syndrome, Postviral Fatigue | 24 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07726082) |
| July 24, 2026 | NCT07724834 | CD19-B Cell Depletion in PAIS-ME/CFS Patients | Charite University, Berlin, Germany | Phase 2 | Not yet recruiting | Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID), Myalgic Encephalomyelitis/Chronic... | 38 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07724834) |
| July 23, 2026 | NCT07722000 | Different Treatment Options Used for Post Covid-19 Syndrome | Beni-Suef University | Not applicable | Completed | COVID-19, Post COVID-19 Syndrome, Ginkgo Biloba, Piracetam | 90 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07722000) |
| July 20, 2026 | NCT07714889 | Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID | Toivoa Inc | Not applicable | Withdrawn | Long Covid, Depression, Anxiety | 0 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714889) |
| July 20, 2026 | NCT07714213 | Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE) | Christiana Franke | Phase 2 | Not yet recruiting | Post-acute Infectious Syndrome (PAIS), Post-COVID-19 Condition (PCC or Long COVID) | 138 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714213) |
| July 16, 2026 | NCT07709234 | Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue | University of Las Palmas de Gran Canaria | Not applicable | Not yet recruiting | Long COVID, Post-COVID Conditions, Fatigue, Cognitive Dysfunction | 20 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07709234) |
| July 13, 2026 | NCT07697261 | Fatigue in Long COVID | McMaster University | Not applicable | Not yet recruiting | Long COVID | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697261) |
| July 9, 2026 | NCT07694232 | A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID | St. Mary's University, Twickenham | Not applicable | Not yet recruiting | Long COVID, Long COVID Symptoms | 120 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07694232) |
| July 2, 2026 | NCT07682402 | Taurine Supplementation in Adolescents With Post-COVID Condition | University of Alberta | Phase 1/2 | Not yet recruiting | Long COVID, Post COVID-19 Condition, PASC Post Acute Sequelae of COVID 19 | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682402) |
| June 22, 2026 | NCT07661862 | PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID | University of Tasmania | Not applicable | Recruiting | Long COVID | 577 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661862) |
| June 16, 2026 | NCT07651371 | Effects of a Physical Rehabilitation Program on Long COVID | Universidade do Estado do Pará | Not applicable | Completed | Long Covid | 74 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07651371) |
| June 4, 2026 | NCT07627815 | Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID | ParagonClinicals Inc. | Phase 2 | Recruiting | Long COVID | 82 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07627815) |
| June 2, 2026 | NCT07621588 | Diaphragmatic Breathing Exercises With KOTS Currents in Patients With Long COVID | Universidad Pontificia de Salamanca | Not applicable | Completed | Long COVID Syndrome, Post-Acute COVID-19 Syndrome | 9 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621588) |
| May 20, 2026 | NCT07600320 | Fareon Open Label Device Clinical Trial | Icahn School of Medicine at Mount Sinai | Not applicable | Enrolling by invitation | Cognitive Dysfunction, Acquired Brain Injury, Traumatic Brain Injury | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600320) |
| May 19, 2026 | NCT07597902 | SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction | Icahn School of Medicine at Mount Sinai | Phase 2 | Recruiting | Post-acute Sequelae of COVID-19, Long COVID | 150 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07597902) |
| May 5, 2026 | NCT07567274 | DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury | Leading Edge Clinic | Phase 2 | Enrolling by invitation | Tinnitus | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07567274) |
| April 30, 2026 | NCT07560059 | Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV) | Algerian Society of Diabetology | Observational | Completed | Diabetes Mellitus, COVID-19, Post-Acute COVID-19 Syndrome | 201 | Algeria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07560059) |
| April 30, 2026 | NCT07559994 | Diagnostic and Clinical Management of Non-Obstructive Myocardial Ischemia in Patients With Long Covid-19 Syndrome and New Onset Chest Pain | Fundacion Investigacion Interhospitalaria Cardiovascular | Not applicable | Active not recruiting | Angina (Stable), INOCA (Ischemia With Non Obstructive Coronary Artery Disease), Long COVID-19 Syndrome | 108 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07559994) |
| April 28, 2026 | NCT07553897 | Tele-exercise Training Program for Long COVID | Tri-Service General Hospital (TSGH) | Not applicable | Completed | Long COVID | 120 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07553897) |
| April 22, 2026 | NCT07545499 | Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythms | Hacettepe University | Observational | Recruiting | Post-COVID-19 Syndrome | 50 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07545499) |
| April 22, 2026 | NCT07544186 | Effect of a Non-pharmacological Intervention on Endothelial Function, Body Composition, and Physical Functionality in Recovered COVID-19... | Instituto Nacional de Enfermedades Respiratorias | Not applicable | Completed | Supplemental Nutrition Assistance Program Education, Post COVID Syndrome, Endothelial Function | 43 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07544186) |
| April 15, 2026 | NCT07530757 | SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Not applicable | Recruiting | Post COVID Condition | 100 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07530757) |
| March 27, 2026 | NCT07498504 | Understanding the Long-term Impact of COVID-19 in Adults | NYU Langone Health | Observational | Not yet recruiting | Long COVID, Long Covid19 | 5,205 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07498504) |
| March 6, 2026 | NCT07454395 | Is Swimming a More Tolerable Form of Movement for Individuals With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome? | Simon Fraser University | Not applicable | Suspended | ME/CFS, Long COVID, Post- COVID-19 Syndrome, POTS - Postural Orthostatic Tachycardia Syndrome, Fibromyalgia... | 50 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07454395) |
| February 27, 2026 | NCT07435805 | Long-Term Health Effects of Previous Coronavirus Disease 2019 (COVID-19) in Patients Undergoing Preoperative Anesthesia Evaluation | Elazıg Fethi Sekin Sehir Hastanesi | Observational | Completed | Post-COVID Condition, Long COVID, Sequelae of COVID-19 | 400 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07435805) |
| February 24, 2026 | NCT07429903 | Effect of Daily Walnut Consumption on Memory in Subjects With Long-COVID | University of California, Los Angeles | Not applicable | Completed | Long-COVID, Brain Fog, Cognition, Memory | 31 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07429903) |
| February 18, 2026 | NCT07418567 | A Fasting Pilot Study for Long COVID | Université de Sherbrooke | Not applicable | Completed | Long COVID Syndrome | 25 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07418567) |
| February 9, 2026 | NCT07397910 | Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection | Universidad Católica San Antonio de Murcia | Not applicable | Not yet recruiting | Long COVID | 40 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397910) |
| February 9, 2026 | NCT07397130 | Inspiratory Muscle Pressure and Diaphragmatic Strength in Women With Long COVID-19: A Pressure Biofeedback-Guided Training Study | RSUP Persahabatan | Not applicable | Completed | Long COVID-19 Syndrome, Post COVID Syndrome Long Covid, Post COVID-19 Syndrome | 80 | Indonesia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397130) |
| February 5, 2026 | NCT07388550 | Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 | Not yet recruiting | Post-Acute COVID-19 Syndrome | 15 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07388550) |
| January 29, 2026 | NCT07374562 | Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial | Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec | Not applicable | Recruiting | Long COVID | 40 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374562) |
| January 22, 2026 | NCT07359482 | sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 3 | Recruiting | Post-COVID, POST-Covid 19, Post-COVID Conditions | 160 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359482) |
| January 21, 2026 | NCT07356570 | Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort | Hospices Civils de Lyon | Observational | Recruiting | Post-Acute COVID-19 Syndrome | 150 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07356570) |
| January 21, 2026 | NCT07355751 | The Effect of Acupuncture Treatment on Cognitive Functions and Brain Networks for Long COVID | Tingting Luo | Not applicable | Not yet recruiting | Long Covid | 108 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07355751) |
| January 15, 2026 | NCT07343856 | Long COVID Diagnostic Reactivity Assesment Test | Oncology Center,Ministry Of Heath,Uzbekistan | Not applicable | Enrolling by invitation | Long COVID, Post-Acute Sequelae of SARS-CoV-2 Infection | 50 | Uzbekistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07343856) |
| January 12, 2026 | NCT07332338 | Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition | StemCyte, Inc. | Not applicable | Available | Post-COVID-19 Condition, Post-COVID Condition, Post-COVID Syndrome, Long COVID, Chronic Fatigue, Chronic Fatigue... | Not listed | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07332338) |
| January 5, 2026 | NCT07316127 | Immunoadsorption in Autoimmune Long COVID | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 | Recruiting | Long COVID, Long COVID Syndrome, Long COVID-19 Syndrome, Post COVID Syndrome | 70 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07316127) |
| December 31, 2025 | NCT07312409 | Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID? | York University | Observational | Recruiting | Long COVID Syndrome | 30 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07312409) |
| December 31, 2025 | NCT07312357 | Whole-Body Electrostimulation for Functional Recovery in Post-COVID Syndrome | Universidad Rey Juan Carlos | Not applicable | Not yet recruiting | Post COVID Syndrome Long Covid, Post COVID Syndrome, Long COVID Fatigue, Long Covid | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07312357) |
| December 22, 2025 | NCT07298005 | Sonlicromanol in Post-COVID | Michele van Vugt | Phase 2 | Recruiting | Post COVID Condition | 80 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298005) |
| December 19, 2025 | NCT07295483 | Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study) | Instituto de Investigación Biomédica de Salamanca | Observational | Recruiting | Persistent COVID Condition | 400 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07295483) |
| December 16, 2025 | NCT07285707 | Acupuncture and Chinese Herbal Medicine for Long COVID | Southern California University of Health Sciences | Not applicable | Recruiting | Long COVID | 10 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07285707) |
| December 12, 2025 | NCT07280572 | RECLAIM Adaptive Platform Trial for PCC Treatments | Janneke van de Wijgert | Phase 3 | Enrolling by invitation | Post COVID Condition | 1,250 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07280572) |
| December 12, 2025 | NCT07279272 | The Effect of the Human Regenerator Jet Device on the Quality of Life of Adult Individuals \[HR-QoL\] | University of Athens | Not applicable | Completed | Chronic Stress, Chronic Fatigue, Chronic Pain, Post-COVID / Long-COVID | 40 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07279272) |
| December 12, 2025 | NCT07278388 | Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2 | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Not applicable | Recruiting | PASC Post Acute Sequelae of COVID 19, Fatigue | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07278388) |
| December 11, 2025 | NCT07278206 | Brain Stimulation in Long COVID | Amsterdam UMC, location VUmc | Not applicable | Recruiting | Long COVID, PASC Post Acute Sequelae of COVID 19, Post COVID-19 Condition (PCC) | 66 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07278206) |
| November 28, 2025 | NCT07254377 | Design and Validation of Innovative Strategies Based on Dual-Task Approach | I.R.C.C.S. Fondazione Santa Lucia | Not applicable | Active not recruiting | Stroke, Multiple Sclerosis, Parkinson Disease, Dual Task Exercises, Long COVID | 48 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254377) |
| November 4, 2025 | NCT07224490 | Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease | Stephanie B. Seminara, MD | Phase 1 | Recruiting | Reproductive Disorder, Neurodegeneration, SARS-CoV 2, Long COVID | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224490) |
| October 14, 2025 | NCT07216040 | Harnessing Optimism and Perseverance in the Face of Long COVID-Español | Icahn School of Medicine at Mount Sinai | Not applicable | Not yet recruiting | Post-Acute COVID-19 Syndrome | 25 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216040) |
| September 29, 2025 | NCT07197138 | IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition | Max-Planck-Institute of Psychiatry | Not applicable | Recruiting | Depressive Disorder, Post-Acute COVID-19 Syndrome | 42 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07197138) |
| September 24, 2025 | NCT07190105 | Vagal Approaches on Long COVID-19 | Leidos Life Sciences | Not applicable | Completed | Long COVID Symptoms | 546 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07190105) |
| September 24, 2025 | NCT07189936 | Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS | Vanderbilt University Medical Center | Phase 2 | Recruiting | Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), SARS CoV 2 Infection, Long COVID19 | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07189936) |
| September 19, 2025 | NCT07184385 | A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition | StemCyte, Inc. | Phase 3 | Not yet recruiting | Long COVID, Post-COVID-19 Condition, Post-COVID Syndrome, Post-COVID Condition | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07184385) |
| September 5, 2025 | NCT07156994 | Development of Voice Biomarkers of Frequent COVID-19 and Long Covid-related Symptoms Based on Data From Users of the Long COVID Companion... | Luxembourg Institute of Health | Observational | Recruiting | Long COVID | 300 | Luxembourg | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07156994) |
| September 4, 2025 | NCT07154199 | Transcranial Ultrasound Stimulation for Cognitive Function Modulation in Patients With Post COVID-19 Brain Fog | Xuanwu Hospital, Beijing | Not applicable | Recruiting | COVID-19, Brain Fog, Long COVID, Transcranial Ultrasound Stimulation | 40 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07154199) |
| August 24, 2025 | NCT07140094 | Long-Covid-19 Alleviation Through Learning Mindfulness Study | Columbia University | Not applicable | Recruiting | Long COVID, Long Covid19, Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, COVID... | 400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07140094) |
| August 21, 2025 | NCT07134673 | Mitochondrial Function in Peripheral Blood Mononuclear Cells, Muscle, and Skin of Long COVID Patients | Universitair Ziekenhuis Brussel | Observational | Recruiting | Long COVID, Post-COVID-19 Condition | 54 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07134673) |
| August 17, 2025 | NCT07128082 | The Long COVID Treatment Trial | Scripps Translational Science Institute | Phase 2 | Active not recruiting | Long COVID | 1,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07128082) |
| August 14, 2025 | NCT07123727 | A Study to Examine Anktiva for the Treatment of COVID-19. | ImmunityBio, Inc. | Phase 2 | Recruiting | Long COVID, Long COVID Syndrome, Long Covid 19 | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07123727) |
| August 8, 2025 | NCT07110714 | Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients | Eggensberger OHG | Not applicable | Recruiting | Post COVID-19 Condition, Post COVID-19 Condition (PCC), Post COVID-19, Post COVID-19 Syndrome, Long COVID-19 Syndrome | 30 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07110714) |
| August 6, 2025 | NCT07108036 | A Study to Assess Anktiva in Patients With Long Covid-19. | ImmunityBio, Inc. | Phase 2 | Recruiting | Long COVID | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07108036) |
| July 29, 2025 | NCT07090564 | Treatment Outcomes in PASC Patients With Neurocognitive Impairment | Ohio State University | Observational | Completed | Long COVID | 171 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07090564) |
| July 29, 2025 | NCT07090486 | A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions. | Pfizer | Observational | Completed | COVID-19 | 14,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07090486) |
| July 23, 2025 | NCT07079787 | Telerehabilitation Decision Support System: Pilot Testing Protocol | University College, London | Not applicable | Not yet recruiting | Stroke, Mild Cognitive Impairment (MCI), Vestibular Disease, Long Covid-19 | 30 | Germany, Greece, Portugal, Thailand, United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07079787) |
| July 22, 2025 | NCT07076862 | Multiparametric \[18F\]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC) | University of California, Davis | Early phase 1 | Recruiting | PASC Post Acute Sequelae of COVID-19 | 51 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07076862) |
| July 20, 2025 | NCT07074158 | Microbial and Cytokine Signatures in Long COVID Patients | Palo Alto Medical Foundation | Observational | Enrolling by invitation | Post-Acute COVID-19 Syndrome | 150 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07074158) |
| July 4, 2025 | NCT07051954 | Effectiveness of Functional Respiratory Muscle Training in Post-COVID-19 Syndrome | Hacettepe University | Not applicable | Recruiting | Post COVID-19 Syndrome, Functional Inspiratory Muscle Training, Core Stabilization | 40 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07051954) |
| July 1, 2025 | NCT07046442 | Effect of Pulmonary Rehabilitation and Physical Activity on COVID-19 Long-Term Symptoms (PuReCOVID) | University of Parma | Observational | Completed | COVID - 19 | 40 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07046442) |
| July 1, 2025 | NCT07046208 | Effects os Physiotherapeutic Rehabilitation on Function Autonomic and Inflammatory in Patients With Long Covid | Universidade do Estado do Pará | Not applicable | Not yet recruiting | Long COVID, Heart Rate Variability (HRV), Cardiac Biomarkers, Inflammatory Biomarkers | 58 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07046208) |
| June 15, 2025 | NCT07021794 | SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID) | Nancy Klimas | Phase 2 | Recruiting | Post-COVID / Long-COVID | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07021794) |
| June 10, 2025 | NCT07013903 | Effects of Hydrotherapy During Post-COVID-19 Rehabilitation | Schön Klinik Berchtesgadener Land | Not applicable | Recruiting | Post-COVID / Long-COVID, POST-Covid 19, Post COVID Syndrome, Post-COVID Condition | 50 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013903) |
| June 5, 2025 | NCT07005947 | Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project | CND Life Sciences | Observational | Completed | Long COVID-19, Acute COVID-19, Postural Orthostatic Tachycardia Syndrome (POTS), Diabetic Neuropathy | 237 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07005947) |
| June 5, 2025 | NCT07005921 | QEEG-NEUROFEEDBACK FOR COGNITIVE REHABILITATION IN LONG COVID-19 SURVIVORS WITH BRAIN FOG | Jade Carvalho Da Silva | Not applicable | Completed | Post-Acute COVID-19 Syndrome, Long COVID, Brain Fog | 40 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07005921) |
| May 30, 2025 | NCT06996314 | Effects of Auricular Vagus Nerve Stimulation Combined With Slow-paced Breathing on Individuals With Postural Orthostatic Tachycardia... | Ali Kapan | Not applicable | Not yet recruiting | Postural Orthostatic Tachycardia Syndrome (POTS), Post-acute COVID-19 Syndromes | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06996314) |
| May 28, 2025 | NCT06992401 | Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism | Tamara C Tamas | Observational | Not yet recruiting | Post-Acute Sequelae of SARS-CoV-2 Infection, Long COVID, Long COVID Fatigue, Long COVID Syndrome, COVID 19 Associated... | 50 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06992401) |
| May 15, 2025 | NCT06974084 | A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of... | HealthBio, Inc. | Phase 2/3 | Not yet recruiting | Long COVID | 252 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06974084) |
| May 15, 2025 | NCT06974058 | Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms | Liaquat University of Medical & Health Sciences | Not applicable | Completed | Long COVID | 15 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06974058) |
| May 13, 2025 | NCT06968104 | Vagus Nerve Stimulation to the Ear to Improve Symptoms in Post-COVID-19 and ME/CFS | University of Luxembourg | Not applicable | Active not recruiting | Post-COVID / Long-COVID, ME/CFS | 48 | Luxembourg | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06968104) |
| May 7, 2025 | NCT06960928 | Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19 | Icahn School of Medicine at Mount Sinai | Phase 3 | Recruiting | Long COVID-19 | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06960928) |
| April 30, 2025 | NCT06952127 | Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO). | Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec | Not applicable | Completed | Long COVID-19 Syndrome, Long COVID, Long COVID Syndrome | 22 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06952127) |
| April 23, 2025 | NCT06940609 | Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation | University of New Mexico | Phase 2 | Recruiting | Long COVID, Long COVID Syndrome, Long COVID-19 Syndrome, PASC, PASC Post Acute Sequelae of COVID 19 | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06940609) |
| April 18, 2025 | NCT06933173 | RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis | University of Alberta | Not applicable | Recruiting | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | 200 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06933173) |
| April 17, 2025 | NCT06933017 | Feasibility of an Augmented Two-Day Step Test and Causal Modeling for Post-Exertional Symptom Exacerbation in Post Covid-19 Syndrome | Universitair Ziekenhuis Brussel | Not applicable | Completed | Long COVID | 25 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06933017) |
| April 17, 2025 | NCT06932237 | Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans | VA Office of Research and Development | Observational | Recruiting | Neuro-PASC, Long COVID | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06932237) |
| April 15, 2025 | NCT06928506 | Effect of Hi-OxSR for the Treatment of Post COVID Condition | University Health Network, Toronto | Not applicable | Recruiting | Long COVID, Post COVID-19 Condition, Post Acute Sequelae of COVID-19 | 120 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06928506) |
| April 15, 2025 | NCT06928480 | Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in People With Long... | Instituto de Investigación Sanitaria Aragón | Not applicable | Recruiting | Long Covid-19, Emotional Disorder, Anxiety, Depression Disorders, Emotion Regulation | 90 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06928480) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Icahn School of Medicine at Mount Sinai | 5 | May 20, 2026 |
| University of Alberta | 3 | July 2, 2026 |
| Universidade do Estado do Pará | 2 | June 16, 2026 |
| Hacettepe University | 2 | April 22, 2026 |
| Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2 | April 15, 2026 |
| Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec | 2 | January 29, 2026 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 | January 22, 2026 |
| StemCyte, Inc. | 2 | January 12, 2026 |
| Universitair Ziekenhuis Brussel | 2 | August 21, 2025 |
| ImmunityBio, Inc. | 2 | August 14, 2025 |
| VA Office of Research and Development | 2 | April 17, 2025 |
| University of Tartu | 2 | February 4, 2025 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 | November 4, 2026 |
| Invivyd, Inc. | 1 | October 27, 2026 |
| Hospital Donostia | 1 | October 22, 2026 |
| Hopitaux de Saint-Maurice | 1 | October 19, 2026 |
| Hospital de Basurto | 1 | October 19, 2026 |
| Oxford Brookes University | 1 | October 14, 2026 |
| Central Hospital, Nancy, France | 1 | October 13, 2026 |
| Liliana Barrios | 1 | August 24, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 64 | October 22, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 32 | October 19, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 18 | October 27, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 6 | November 4, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 3 | February 5, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 2 | May 15, 2025 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 1 | July 2, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 1 | July 22, 2025 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 1 | January 24, 2025 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 40 | November 4, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 12 | October 22, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 11 | June 4, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 6 | July 24, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 5 | August 11, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 5 | January 22, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 4 | October 14, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 4 | August 4, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 4 | June 16, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 3 | October 19, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 3 | August 24, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 3 | April 28, 2026 |
| [Mexico](https://specstream.ai/data/clinical-trials/country/mexico) | 2 | April 22, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 2 | January 21, 2026 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 2 | December 12, 2025 |
| Luxembourg | 2 | September 5, 2025 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 2 | August 21, 2025 |
| [Estonia](https://specstream.ai/data/clinical-trials/country/estonia) | 2 | February 4, 2025 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 1 | July 23, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 1 | June 22, 2026 |
| Algeria | 1 | April 30, 2026 |
| [Indonesia](https://specstream.ai/data/clinical-trials/country/indonesia) | 1 | February 9, 2026 |
| [Uzbekistan](https://specstream.ai/data/clinical-trials/country/uzbekistan) | 1 | January 15, 2026 |
| [Portugal](https://specstream.ai/data/clinical-trials/country/portugal) | 1 | July 23, 2025 |
| [Thailand](https://specstream.ai/data/clinical-trials/country/thailand) | 1 | July 23, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).